Dendreon (DNDN) Falls On Rumors of Unexpected FDA Panel On Provenge
Tweet Send to a Friend
Shares of Dendreon Corp. (Nasdaq: DNDN) are seeing pressure this morning, which could be related to a report that the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


